BioArctic AB

2 clinical trials · Sponsor

Record	Firm	Date
Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy (NCT06671938)	BioArctic AB	2024-10-24
Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects (NCT02490501)	BioArctic AB	2015-06-01

Every clearance here is in the API, with alerts when new ones post.